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ABSTRACT
Arboviruses are viruses transmitted by hematophagous arthropod vectors. Many of these viruses
pose a threat to human health. While some infections may be asymptomatic, others may produce febrile
illness, or manifest in life threatening conditions. Symptomatic diagnosis of patients with generalized
febrile illness can be confounded due to the various diseases that present clinically in the same manner,
and a lack of available diagnostic tests. Surveillance efforts can be used to create awareness
about the prevalence of neglected tropical arthropod-borne pathogens, such as Oropouche virus
(OROV), and inform preparedness measures for disease outbreaks (SURVEILLANCE
SENTENCE). OROV is an arbovirus and the etiologic agent of human and animal disease. The primary
vector of OROV is thought to be the biting midge, Culicoides paraenesis, though Culex
quinquefasciatus, Cq. venezuelensis, and Aedes serratus mosquitoes are considered secondary
vectors. There are no vaccines, diagnostics, or robust surveillance systems in place for OROV
despite OROV being found in human patients in numerous countries that share border with Colombia:
Ecuador, Peru, Brazil. In this study, synthesis of known data through review of published literature
regarding OROV and vectors was done to determine if ecological variables could be associated with
OROV prevalence and thus inform targeted surveillance efforts in resource strapped environments.
Some common features were observed more frequently than others, though no one characteristic
was statistically significantly associated with the presence of OROV using logistic classification
models. Although there have not been any documented cases of OROV in Colombia, the presence of C.
paraensis, the primary vector of OROV has been documented. However, when nearly 700 febrile patients
were screened for OROV, none were positive by RT-qPCR. This indicates that while Colombia is
presumably ecologically suitable for OROV circulation (given the presence of the vector), OROV has not
emerged in that region. Altogether, this research has identified a significant gap in our understanding of
OROV circulation, the eco-environmental drivers of transmission, and its emergence potential and
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indicates that more research is needed to identify those variables that may serve as ecological markers for
transmission and emergence.
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CHAPTER 1. ZOONOTIC VIRUS TRANSMISSION AND THE NEED FOR
ENHANCED SURVEILLANCE
1.1. Introduction to Arbovirus Transmission
The term arbovirus (arthropod-born virus) refers to any virus that is transmitted by an
arthropod vector 1, 2. A vector is an arthropod that is capable of acquiring and transmitting
disease causing agents 1. These vectors are most often hematophagous (blood feeding)
arthropods and include numerous species of mosquitos, biting midges, and ticks 1, 2.
Vector competence is the ability of a vector to transmit a virus 3. For a vector to be
considered competent for a particular virus, a series of events must take place within the vector
itself. Generally, hematophagous arthropod vectors first must ingest a bloodmeal from a viremic
host. The virus must then get past several barriers in the process of infecting and replicating in
the arthropod vector. The route of the virus begins with acquisition from a bloodmeal, then
infecting midgut cells, disseminating into secondary tissues, infecting salivary glands, and lastly
being expectorated with vector saliva into a susceptible host during a subsequent biting event 4, 5.
Arthropod vectors generally have four tissue barriers that a pathogen must surpass for
transmission to occur. These barriers include the midgut infection barrier, midgut escape barrier,
salivary gland infection barrier, and salivary gland escape barrier 6-8.
Arboviruses are generally maintained in two different types of transmission cycles: the
sylvatic cycle and the enzootic cycle. The sylvatic cycle is when the virus is maintained or
amplified in a transmission cycle consisting of wild animals and associated vector species. An
example of this is the cycle of Zika virus (ZIKV) transmission between sylvatic mosquitoes and
non-human primates. In 1947 ZIKV was found isolated from a rhesus macaque in Uganda 9, 10.
Within a year of this discovery, ZIKV was also isolated from the known yellow fever virus
1

(YFV) sylvatic vector, Ae. Africanus 9, 10. This data suggested that ZIKV was circulating in a
sylvatic transmission cycle between mosquitoes and non-human primates in the Zika forest,
during which the mosquito becomes infected after ingesting virus from a non-human primate and
transmitting virus to another non-human primate. In an enzootic cycle, viruses are maintained
between humans and the vectors that feed on them. For example, YFV outbreaks in human
populations led to the discovery of viral circulation between humans and the known urban
mosquito, Ae. aegypti 11. Viruses can spillover from a sylvatic cycle to an enzootic cycle when
there is contact between an infected arthropod vector and a human4. This can happen either when
an infected arthropod is introduced into urban areas or when humans venture into arthropod
habitats such as forests and jungles 12, 13. Spillover events often involve a bridge vector, or
arthropod capable of feeding on both reservoir hosts and humans, bridging sylvatic and enzootic
transmission cycles 14, 15.
A combination of many factors plays a role arbovirus transmission. The arthropod vector
itself must be competent for the particular virus. Vector distribution is a key factor in arbovirus
transmission as the vector serves as a main source of pathogen transmission and expansion.
Ecological characteristics such as temperature, land use, and access to water sources are
important to the survival and maintenance of a particular vector life cycle 16-18. Reservoir hosts
that are essential to the long-term maintenance and propagation of viruses must interact with
arthropod vectors for the vector to contract and transmit the virus. In addition, for pathogens
often times spillover events are aided by a bridge vector that connect the sylvatic and enzootic
transmission cycles. This suggests that vector-human and vector-reservoirs must be within a
certain proximity for these events to take place. Humans, reservoir hosts, vectors, and viruses are
all required for successful, ongoing transmission of arboviruses 19, 20.
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1.2.Human Health Risk
Numerous arboviruses are major public health concerns 21, 22. Arboviral outbreaks cause
clusters of febrile illness, neurologic conditions, neonatal defects, and fatalities in human
populations 21. Disease burden can be measured in disability-adjusted life years (DALYs).
DALYs are calculated using the sum of years of life lost and years lived with disability for any
given disease-causing agent 23. Chikungunya (CHIKV), dengue (DENV), and Zika (ZIKV)
viruses are three examples of such arboviruses that have resulted in outbreaks affecting human
populations. In combination, these three arboviruses resulted in the loss of nearly 500,000
DALYs in the Colombian population alone between the years of 2013-2016 23. Within a period
of three years, the combination of these three viruses resulted in over 9 million cases of infection
23

. Of the nearly 500,000 DALYs, 31,000 were years of life lost (nearly 1,400 deaths) and

460,000 were years lived with disability 23. These disabilities included post-DENV chronic
fatigue, CHIKV related chronic arthritis, and ZIKV associated microcephaly and GBS 23.
CHIKV does not result in a high mortality rate, but it causes fever, myalgia, headache
and arthralgia in symptomatic patients. The arthralgia associated with CHIKV can be mild or
severe and last anywhere from days to years 24. CHIKV has been found in Asia, throughout
central and parts of South Africa, Asia, and islands off the coast of Africa including La Reunion
and Madagascar 24. CHIKV is transmitted primarily by Aedes spp. mosquitoes and can infect
humans, non-human primates, rodents, and birds 24. There is no currently licensed vaccine for
CHIKV, and treatment involves symptomatic treatment with non-steroidal anti-inflammatory
(NSAID) medication and fluids 24.
DENV is the most common cause of arbovirus-related disease around the world,
infecting 390 million people per year 22, 25. There are 4 serotypes of DENV, all of which typically
3

result in fever, rash, myalgia, and headache. Many cases of DENV are self-limiting but severe
instances may be fatal 26. In severe cases, DENV can result in Dengue Shock Syndrome or
Dengue Hemorrhagic Fever. DENV can be found throughout the world with many epidemics
taking place in tropical and subtropical regions 26. Similar to CHIKV, DENV is primarily
transmitted via Aedes spp. mosquitoes 25. Currently there is one DENV vaccine that is licensed
but this vaccine is only recommended to be administered to patients that have been previously
infected with DENV. The DENV vaccine was shown to increase the risk of severe DENV
disease upon exposure to wild DENV infections27. There is no medication to cure DENV but
patients with infection are treated to ease symptoms.
Clinical manifestations of ZIKV include fever, headache, myalgia, rash, and
conjunctivitis 28. Often times, ZIKV is mild but one of the most concerning aspects of
contracting ZIKV during pregnancy is Congenital Zika Syndrome. This syndrome results in
microcephaly, decreased brain tissue, and brain damage in newborns. ZIKV has also been
associated with Guillain-Barre syndrome, which is an autoimmune disease that can result in
paralysis 29, 30 . ZIKV has been found in the Pacific islands, Africa, Latin America, Asia, and
North America 31. This virus is primarily transmitted by Aedes spp. mosquitoes but is also
capable of sexual, blood-transfusion, and maternal-to-fetus transmission 32. There is currently no
vaccine available for the prevention of ZIKV and infected patients 33.
OROV, an arborvirus that is beginning to gain more recognition in South America, can
present with generalized febrile illness in the early stages of infection like many DENV, ZIKV,
or CHIKV infections 34. This virus was initially identified in 1955 in Trinidad in a forest worker
and has resulted in clusters of infection in Brazil, Peru, Panama, Suriname, and most recently
French Guiana 35-37. The presumptive primary vector for OROV is C. paraensis, while a number
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of mosquito species have been implicated in the enzootic cycle including Cx. quinquefasciatus,
Co. venezuelensis, and Ae. serratus 34, 35. Avian species, non-human primates, and sloths have
been found to carry OROV but none of these have been definitively identified as a primary
reservoir host 34, 35. OROV has been seen to result in encephalitis in severe cases, though this
manifestation appears to be a rare occurrence 34, 35, 38. Oropouche Fever, caused by OROV, has
been recognized as a neglected tropical disease of veterinary and public importance 39, 40.
Increasing screening and surveillance for this virus in human and animal populations will help to
gain knowledge about virus and vector distribution, reservoir hosts, and characteristic symptoms
of OROV 41, 42.
The commonalities of arboviruses can be seen with the examples of CHIKV, DENV,
ZIKA, and OROV. Clinical presentation during the early stages of infection is of mild
generalized febrile illness43. These viruses are all zoonotic and initially emerged from wild
animal populations resulting in spillover event aided by arthropod vectors 28, 44. Preventative
vaccination is not an option (with the exception of DENV, where a licensed vaccine is available
but is not generally recommended for naïve populations) and treatment options are limited to
palliative care and address of symptoms 27, 28, 33.
Knowledge of viral circulation and distribution is often only gained after the virus has
been identified42. Emerging viruses can be identified through surveillance programs for public
health42. In addition, continued surveillance of emerging diseases throughout disease progression
can reveal symptoms that may be virus specific. For example, after the ZIKV outbreak in Brazil
in 2015 there was a marked increase in the number of infants born with malformations such as
microcephaly45 . After surveillance efforts revealed the coincidental findings, a retrospective
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study was done in French Polynesia from the 2013 ZIKV outbreak, which supported the
association between ZIKV and microcephaly 46
Symptomatic diagnosis of patients with generalized febrile illness can be confounded due
to the various diseases that present clinically in the same manner (Table 1.1.)47-51 . This can lead
to misdiagnosis and undetected circulation of emerging viruses 52, 53. It has been speculated that
the number of ZIKV cases during the 2013-2015 outbreak in the Americas was underestimated
because of misdiagnosis as either DENV or CHIKV 54. Surveillance efforts during outbreaks of
generalized febrile illness where a variety of viruses are screened for could reveal the circulation
of an emerging virus42. This surveillance would also differentiate diagnoses in locations where
arboviral co-circulations exist such as Brazil 54. Accurate diagnoses through surveillance efforts
also informs disease epidemiology by providing spatial and temporal data55.

6

Table 1.1. Generalized and Characteristic Symptoms of Select Viruses Producing Febrile Illness
Virus

Generalized Symptoms

Characteristic/severe Symptoms

Zika virus (ZIKV)

Fever, myalgia, arthralgia, retro-

Fetal malformations (microcephaly, Guillain-Barre

orbital pain, rash

Syndrome), encephalitis

Chikungunya virus (CHIKV) Fever, myalgia, headache, arthralgia,

Severe arthralgia (can be recurrent)

retro-orbital pain, rash
Dengue virus (DENV)

Fever, myalgia, headache, rash

Dengue Hemorrhagic Fever, Dengue Shock Syndrome

Influenza

Fever, headache, myalgia, fatigue

Sore throat, nasal congestion, pneumonia

Oropouche virus (OROV)

Fever, headache, myalgia, arthralgia

Meningitis/encephalitis

Yellow fever virus (YFV)

Fever, headache, myalgia, fatigue

Jaundice, nausea, vomiting

Severe acute respiratory

Fever, myalgia, headache, fatigue

Nasal congestion, respiratory failure, diarrhea, anosmia,

syndrome coronavirus 2

ageusia

(SARS-CoV-2)
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1.3. Surveillance
Infectious disease surveillance is broadly defined as monitoring the health of a population
56

. The primary goal of surveillance is to monitor disease burden with the hopes of being able to

identify future outbreaks and newly emerging pathogens 56. Disease surveillance involves
multiple aspects to gather comprehensive data to create awareness about disease prevalence and
make informed decisions regarding preventative and preparedness measures for outbreaks 56.
Identifying potential outbreak locations for can be examined for a particular disease by
examining known disease epidemiology57, 58. This data can then be used to educate preventative
and treatment measures for affected populations56. Continued disease surveillance can monitor
the progress of disease control to make adjustments as needed to protect populations efficiently56
. Ultimately, by continued disease surveillance, being able to identify and readily respond to
outbreaks would prevent an outbreak from overwhelming entire communities and spreading to
others56, 59.
There are numerous methods of surveillance used around the world depending on the
goals of the surveillance program 56. There are targeted methods of surveillance that seek
specimens that meet a particular criteria for a specific disease or group of diseases in a given
location56. In these cases, laboratory confirmation is typically required, and sample data is
collected on an individual basis56. For example, OROV was found to be the etiologic agent of
febrile illness in 2 patients in Brazil. These patients provided individual accounts of medical
records, location, time off illness onset, and symptoms experienced60. On the other hand, some
surveillance methods may be more generalized, by which specimens are collected on a routine
basis and used to screen for various pathogens 56. An example of this is the surveillance system
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for West Nile virus in the state of Louisiana, whereby mosquitoes are screened for the presence
of virus in an effort to inform vector control efforts61. Regardless of the type of surveillance
used, these tools are critical for being able to identify new and existing pathogens, inform
preventative measures, and ultimately strive for increasing public health and awareness.
Environmental factors including temperature and precipitation are known to be related to
arbovirus transmission 62, 63. Monitoring environmental trends and fluctuations such as
temperature, precipitation, and humidity changes through environmental surveillance can be a
useful tool to predict future arbovirus outbreaks 58, 64, 65 . Statistical and mathematical models
built from ecological input data have frequently been performed to make predictions about future
outbreak risks58, 64, 66. Prediction models are a useful tool to assess outbreak potential and
mitigation measures, but those models still rely on input data that is provided to train an
algorithm58, 64, 66. This input data is often generated from surveillance effort stemming from
previous outbreaks, revealing the importance of efforts to generate and collect surveillance
data58, 64, 66 .
1.4. The Cost of Delayed Surveillance
The most recent SARS-COV-2 pandemic illustrates the importance of continued
surveillance for new and emerging diseases. The outbreak that began in Wuhan, China expanded
worldwide resulting in more than 150 million confirmed cases and over 3 million deaths67 . This
pandemic has also resulted in devastating economic losses, with an estimated 16.2 trillion-dollar
economic loss in the United States alone68. A primary goal of disease surveillance is to be able to
identify and respond to disease outbreaks, which may prevent such overwhelming outcomes. The
use of predictive models have been for drive public health emergency responses. These models
are able to estimate the size and timing of outbreaks, which help to prioritize treatment resources
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and surveillance efforts during disease outbreaks69. During the COVID-19 pandemic, models
were used to inform policies regarding physical distancing, testing, and dispersal of public health
resources70.
DENV circulates in over 100 countries worldwide, affecting nearly 400 million people
annually71. A cost analysis reviewing the economic impact of DENV in Puerto Rico between
2002 and 2010 revealed the economic cost of $46.4 million dollars 72. This estimate includes
DENV illness, surveillance, and vector control methods, where the cost of illness made up $38.7
million dollars (83%) of that cost 72. Of the $7.7 million dollars spent on vector control and
surveillance, only $730,000 went to surveillance 72.
After the ZIKV outbreak in the Americas in 2015, models were made to predict the
number of new cases to be expected in addition to economic impacts associated with continued
disease spread 73. It was predicted that roughly 12 million cases of ZIKV could occur annually in
Latin America if ZIKV became endemic 73. It was also estimated that the economic cost of
neurological disease caused by ZIKV would be about $2.3 billion dollars annually73 . While
these are projected estimates, this data has the potential to be used for outbreak prevention and
preparedness 58, 73.
Emerging and re-emerging arboviruses and neglected tropical diseases should not be
disregarded. The numerous outbreaks, mortality, morbidity, and economic losses produced by
arboviruses such as ZIKV and DENV illustrate the importance of prioritizing neglected tropical
diseases. In addition, emerging diseases that were previously unknown, such as COVID-19, have
resulted in costly and deadly outbreaks, therefore emerging diseases should not be completely
excluded as a possible diagnosis68.
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1.5. Hypothesis and Rationale
Many arboviruses have proven to be pathogens of public health importance, including
OROV. The dynamic nature of transmission involves the arthropod vector, reservoir hosts, and
human hosts, but the identity and role of these pieces of the transmission system for OROV are
relatively uncharacterized. Surveillance for pathogens like OROV is critical to gaining
knowledge regarding these transmission dynamics and implementing mitigation efforts. My
hypothesis is that ecological and environmental characteristics currently available from
published literature can guide surveillance for OROV. My thesis will investigate 1) the known
ecological features associated with OROV detection and 2) the presence of OROV as an
alternative etiology of febrile illness in a Colombian clinical cohort. The goal is to ultimately
inform surveillance of this emerging virus as a pathogen of public health concern.
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CHAPTER 2. CHARACTERIZATION OF THE ECOLOGICAL AND
ENVIRONMENTAL FACTORS ASSOCIATED WITH THE PRESENCE
OF OROV AND THE PRIMARY VECTOR CULICOIDES PARAENSIS: A
SYSTEMATIC REVIEW
2.1. Introduction
The Peribunyaviridae family is a diverse group of viruses that encompasses 4 genera:
Orthobunyavirus, Herbevirus, Pacuvirus, and Shangavirus. This revised classification system
was recently put forth by the International Committee of Viral Taxonomy (ICTV), whereby the
Bunyaviridae family was elevated to an order, Bunyaviridales 75. Accordingly, members of the
Orthobunyavirus genus, which consists of 18 serogroups, have been isolated from numerous
countries in South America, most often Brazil 38, 76-82. The largest serogroup in the
Orthobunyavirus genus, the Simbu sergroup, contain viruses associated with both human and
animal diseases and is comprised of 25 viruses, including Oropouche virus (OROV) 83, 84.
OROV, like all bunyaviruses, is an enveloped, negative-sense, single-stranded RNA
virus, the genome of which consists of three separate segments: small (S), medium (M), and
large (L). These S, M, and L segments encode for the nucleocapsid protein, surface glycoproteins
(Gn and Gc), and the RNA-dependent RNA polymerase, respectively 74. Additionally, the
OROV N gene encodes for non-structural proteins NSs and NSm 85, 86. Not only is the
nucleocapsid protein the most abundant protein produced in infected host cells but it is also the
most immunogenic and is the primary antigen to which host antibodies are made 74, 85.
OROV is maintained in two cycles: the zoonotic cycle (also called the sylvatic cycle),
and the enzootic cycle. In the zoonotic cycle, virus is maintained between vectors and wild
animals, while in the enzootic cycle, the virus cycles between man-biting vectors and humans 35,
39, 87

These two cycles sometimes overlap in the case of a spillover event, which can occur either

when a human becomes inserted in the zoonotic cycle or when a vector is introduced into an
12

enzootic settings, sometimes through a bridge vector 88. OROV mosquito vectors, specifically
Cq. venezuelensis, have been implicated in maintaining the sylvatic cycle of OROV in nonhuman mammalian hosts such as non-human primates, sloths, and some avian species 35, 89
(Figure 2.1.). The primary enzootic vector for OROV has been identified as the biting midge,
Culicoides paraenesis 35, 90-92. In addition to the primary vector, Culex quinquefasciatus,
Coquillettidia venezuelensis, and Aedes serratus are mosquitoes that have been found to transmit
OROV but are considered secondary vectors 35, 89, 93, 94. Each of these mosquito species has been
implicated in maintaining the enzootic cycle for OROV, with Cx. quinquefasciatus also
implicated in the zoonotic transmission cycle 35.

Figure 2.1. Virus transmission. In the sylvatic cycle, the arthropod vector (black), feeds on an infected reservoir host
(red), survives EIP and is able to transmit virus (orange) to a susceptible host (brown). During a spillover event, the
arthropod vector (midge) contracts the virus, survives the EIP and transmits the virus to a human host.

In order to transmit OROV, the midge must first take a bloodmeal from a viremic host, survive
the extrinsic incubation period (EIP) – or time it takes for the virus to replicate and disseminate
through the vector – and finally bite a susceptible vertebrate host, transmitting the virus (Figure
2.2.). The EIP for OROV ranges from 4-8 days (at a temperature of 26.5°C) 91 (Figure 2.2.).
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EIP = 4-8 days

Figure 2.2. Extrinsic incubation period. For successful transmission, the biting midge must survive the EIP, during
which the following take place: 1. Biting midge takes a bloodmeal from a viremic host, 2. Bloodmeal enters hind
part of the mid-gut in the abdomen, 3. Virus attaches and invades gut cells and replicate, 4. Progeny virus escape
into hemocoel and secondary tissues (including salivary glands, 5. Virus replication takes place in salivary gland
cells, after which viral progeny are released into salivary ducts, 6. Viral particles are released from salivary ducts
upon its next bloodmeal.

OROV has been associated with a human febrile illness with generalized symptoms such
as fever, headache, and myalgia 80, 95-97. The first known case of Oropouche fever was described
in Trinidad in 1955. The patient was a young male, whose occupation was to burn coal in the
Melajo Forest, where he often slept 77. Neutralizing antibodies were detected in blood specimens
from forest workers in various forested sites in Trinidad. Neutralizing antibodies were also found
in serum samples of 7/52 monkeys throughout the area 77. Since then, there have been outbreaks
of Oropouche Fever in Brazil, Ecuador, and Peru 81, 97, 98. In the past 2 decades, there has been
progress in developing diagnostic tools for OROV and understanding the pathogenesis of this
virus 99-102.
Before the emergence of Zika and chikungunya in the western hemisphere, OROV was
recognized as being the second most common arboviral cause of human febrile illness in Brazil,
second to dengue virus 103. Though this virus is recognized as the etiologic agent of human
disease and is known to infect animals, there is a scarcity in screening and detection outside of
known areas associated with detected outbreaks 34, 104, 105. Nevertheless, there is increased call for
expanded screening of OROV across South America due to the significant number of cases and
symptom similarity to other arboviruses in order to accurately attribute disease with specific
pathogens 34, 95. The objective of this systematic review (SR) is to characterize the locations
14

where OROV surveillance efforts have either confirmed OROV presence or not, as well as those
locations where surveillance studies have detected the OROV vector independent of virus
detection.
2.2. Material and Methods
2.2.1. Search strategy
To assemble the published literature regarding OROV, an online search in PubMed
database was performed using the term “Oropouche”. We attempted more specific search terms
using “Oropouche virus” AND “South America” but these compound search term drastically
reduced the number of articles returned (77 compared to 143 with only “Oropouche”). In
addition, an additional search was performed using Google Scholar using the terms “Oropouche
Virus” AND “South America”.
To characterize the ecological sites where the primary vector has been studied in South
America, a second literature search was performed using Google Scholar with the search terms:
“Culicoides paraensis” AND “South America”.
2.2.2. Study selection
2.2.2.1. OROV
Inclusion criteria for the OROV studies was defined as the following: molecular and/or
serologic detection, and epidemiological data. Exclusion criteria was defined as following:
reviews, studies without primary data (modeling, assay design, phylogenetics, immunology,
physiology, insecticide investigations), duplicate study populations, Oropouche location (not
virus), thesis/dissertation, book/book chapter, inaccessible/untranslatable, vector competence
studies. The number of records were recorded and were included or excluded based on the
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satisfaction of the defined criteria. Titles were first examined, followed by record abstracts, and
whole paper analysis.
2.2.2.2. Arthropod vector
Inclusion criteria for the arthropod vector of OROV were defined as the following:
epidemiological studies and entomological studies including vector competence and surveillance,
field observations, and abundance. Exclusion criteria was defined as the following: reviews,
studies without primary data, duplicate study populations, thesis/dissertation, book/book chapter,
and inaccessible or untranslatable articles. The total number of articles were recorded and either
included or excluded based on the satisfaction of the defined criteria. Titles were first examined,
followed by abstracts, and whole paper analysis.
2.2.3. Data extraction
2.2.3.1 OROV
The records that satisfied all inclusion criteria with respect to OROV surveillance were
examined for data extraction. Documented study features included: study date and location,
detection of nucleic acid and/or antibodies, laboratory assay performed or vector competence
studies, hosts tested and confirmed positive, and ecological settings.
2.2.3.2. Arthropod vector
Records that satisfied all inclusion criteria for the OROV arthropod vector were
examined for data extraction. The data extracted from C. paraensis literature included:
surveillance date and location, vector species collected, number of vectors collected, collection
methods, ecological settings. Articles that were returned from the Google Scholar database with
the search terms “Culicoides paraensis” and “South America” that concentrated on any
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secondary vectors (Ae. serratus, Cq. venezuelensis, Cx. quinquefasciatus) for OROV were also
included.
2.2.4. Statistics
To determine whether any of the eco-environmental variables affected the odds of an
acute (PCR) or past (antibody) OROV case detection, we built a suite of logistic classification
models, employing variable selection methods. All variables were run as independent variables.
A data reduction method whereby the several variables were combined as below and run as a
uni-, bi-, and tri-variate models for acute and past infections:
a. “livestock,” “military,” “crops,” and “mining” were combined into a single
“anthropological” variable.
b. “river,” “dam,” and “pantanal” were combined into a single “water” variable
c. “primary” or “secondary” forests were combined into a single “forest” variable
A data reduction method whereby the several variables were combined as below and run as a
uni-, bi-, and tri-variate models for the presence of the vector:
d. “livestock,” “military,” and “crops,” were combined into a single
“anthropological” variable.
e. “river,” “dam,” “pantanal,” “swamp,” “streams,” “springs,” and “lakes” were
combined into a single “water” variable
f. “primary,” “secondary,” “mangrove,” and “restiga” forests were combined into a
single “forest” variable
The logistf function was used (package logistf) to fit the models using R Studio (version
1.3.1093) and R version 3.6.3. Significance was assessed at the the !=0.05 level.
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2.3. Results
2.3.1. Study selection
A literature search in PubMed with the term “Oropouche” returned 140 records. A
separate literature search in Google Scholar with the terms “Oropouche virus” AND “South
America” returned 598 records. An additional search in Google Scholar regarding the primary
arthropod vector for OROV was done using the terms “Culicoides paraensis” AND “South
America” returned 173 records. Duplicate records across databases (“Oropouche” in pubmed and
“Oropouche virus” in google scholar) and any article that did not satisfy the parameters of our
inclusion criteria were excluded. A total of 94 articles, which is only 10.3% of all returned
records, satisfied all inclusion criteria. Of the 94 articles included, 63.8% involved the
investigation of OROV while 36.2% of the studies were focused on entomological surveillance
(Figure 2.3.). All articles that met inclusion criteria for literature search of OROV and C.
paraensis are listed in the appendix.
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Articles returned from search
terms = 911

Records after title examination
= 289

Records removed = 622

Records after abstract reviewed =
114

Records removed = 175

Records after full text
analysis = 94

Records removed = 24

Records of OROV
investigation = 56

Records of C. paraenesis
surveillance = 34

Figure 2.3. Systematic review article inclusion and exclusion for OROV and C.paraensis.

2.3.2. Locations from included studies
2.3.2.1. OROV surveillance
Across all 56 articles included for OROV surveillance, there were 8 separate countries
where these investigations took place. There were 37 studies performed in Brazil (63%) 39, 76, 78,
80, 94, 96, 97, 106-135

, followed by 11 studies in Peru (18.6%) 43, 79, 98, 104, 136-142, with the remaining

(18.6%) taking place in Ecuador 38, 43, 81, 95, 143, Paraguay 43, 144, Suriname 145, Trinidad 77, Bolivia
43

, and Costa Rica 146 (Figure 2.4.)
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Figure 2.4. Locations identified by the SR of OROV where the virus has been detected

2.3.2.2. Arthropod vector surveillance
There were 34 articles that met all inclusion criteria for our C. paraensis search. There
were a total of 7 separate countries in which these surveillance efforts took place. There were 21
(60%) articles that were based in Brazil 147-167, 6 (17.1%) studies in Peru 168-173, 4 (11.4%) in
Argentina 174-177, and the remaining (11.4%) taking place in Colombia 92, Paraguay 176, Mexico
178

, and Suriname 179 (Figure 2.5.)
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Figure 2.5. Locations where OROV vectors are distributed throughout S. America according to the SR for C.
paraensis.

2.3.3. OROV detection
OROV detection studies involved both serological and molecular assays across a range of
host species. OROV screening was performed on samples from humans, non-human primates,
arthropods, mammals, avian species, and reptiles. Of the 56 articles that were focused on the
detection of OROV, there were 46 serologic studies 38, 43, 76, 78-81, 94, 96-98, 104, 106-111, 113, 114, 116-118,
120, 121, 124-128, 130-142, 144-146
112, 115, 119, 143

, 7 disease etiology investigations where OROV was confirmed 39, 77, 95,

, and 3 diagnostic development studies 122, 123, 129.

Several methods were used for the detection of both nucleic acid and antibodies:
complement fixation (CF), hemagglutinatin inhibition (HI), neutralization tests, enzyme-linked
immunosorbent assay (ELISA), plaque reduction neutralization test (PRNT), Indirect
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immunofluorescence assay (IFA), virus isolation assays, real-time reverse transcription
polymerase chain reaction (RT-PCR) and quantitative real-time RT-PCR (qRT-PCR), and
Illumina based sequencing. Of these methods, the most commonly used for antibodies detection
was ELISA, whereas the most commonly used method for the presence of OROV nucleic acid
was RT-PCR.
From the 56 articles included in OROV investigations, 9 (16%) of the total 56 studies
found no presence of OROV 111, 116, 127, 130, 133, 135, 142, 144, 146, whereas 47 (84%) of the studies that
screened for OROV found either antibodies to OROV (18 studies) 76, 78, 98, 106-109, 113, 114, 118, 120, 126,
131, 132, 136-138, 145

, OROV nucleic acid (16 studies) 38, 79, 81, 95, 104, 115, 117, 121-123, 128, 129, 134, 139, 140, 143,

or both (13 studies) 39, 43, 77, 80, 94, 96, 97, 110, 112, 119, 124, 125, 133. Humans were tested for OROV
antibodies (11 studies) 78, 98, 106-108, 126, 131, 132, 136, 137, 145, OROV nucleic acid (19 of studies) 38, 79,
81, 104, 111, 115-117, 121-123, 127, 129, 130, 134, 139, 140, 143, 144
120, 124, 125, 138, 141

, or both (17 studies) 39, 43, 77, 80, 94-97, 109, 110, 112, 119,

.

Non-human mammals that were tested for OROV include: non-human primates, sloths,
avian species, rodents, sheep, reptiles, and horses. There were 7 studies that tested non-human
primates, 5 studies tested for antibodies 113, 114, 118, 133, 142, 1 for OROV nucleic acid 128, and 1 for
both 135. There were 3 studies that tested samples obtained from sloths where 2 of these studies
tested for antibodies 133, 146 and 1 study tested for OROV nucleic acid 94. Three studies tested
avian samples for antibodies 96, 97, 126, 2 studies tested rodents for antibodies 97, 126, and 1 study
that tested sheep, caiman, and equine samples for antibodies 76.
2.3.4. Ecological Factors associated with OROV presence
2.3.4.1. Vector presence
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Of these 56 studies returned from the OROV search, 9 studies did not detect the
circulation of OROV. In 8/56 of the OROV search studies, surveillance for known OROV
vectors was conducted and presence confirmed of at least one competent species 77, 94, 96, 97, 113, 117,
124, 125

. Four of these 8 studies (3 in Para, Brazil 97, 117, 125 and 1 in Maranhão, Brazil 124) where

OROV was found documented the presence of C. paraensis. There were 7/56 studies that found
mosquito vectors: Ae. serratus in 4 studies located in Trinidad 77 and Brazil (2 in Para State 94, 96
and 1 in Mato Grosso do Sul State 113), and Cx. quinquefasciatus in 3 studies in Brazil (Para
State 97, 125 and Mato Grosso State 117). In 2/8 studies, C. paraensis and Cx. quinquefasciatus
were both found in Para, Brazil 97, 125, while in another separate study in Para, Brazil, C.
paraensis and Ae. serratus were both found96.
2.3.4.2. Vector Diversity
Of the studies that satisfied the vector criteria, 20 of these articles focused on surveillance
of the OROV primary vector, C. paraensis 92, 147, 148, 157, 158, 160-165, 167, 170-172, 175-179. Even though
the search criteria specified the terms “Culicoides paraensis” and “South America”, there were
14 articles that focused on one or more of the secondary mosquito vectors: Ae. serratus, Cq.
venezuelensis, Cx. quinquefasciatus 149-156, 159, 166, 168, 169, 173, 174. Of the 34 articles, C. paraensis
was found in 18 studies 92, 147, 148, 157, 158, 160-165, 170, 171, 175-179, and each of the 3 mosquito vectors
was present in 7 studies, some of which overlapped 149-156, 160, 168, 169, 174 (Figure 2.6.).
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Figure 2.6. There were 29/34 entomologically focused studies where OROV vectors were collected. There was
overlap in mosquito populations in 7 studies. In 1 study, both the biting midge and a mosquito vector (C. paraensis
and Cx. quinquefasciatus) were found.

2.3.4.3. Anthropogenic Land use
For the OROV search, 15/54 (27.8%) articles provided information regarding
anthropogenic land use. The uses of land in these locations were crop cultivation, livestock
rearing, military outposts, and mining at a frequency of 11 77, 80, 96, 97, 124, 125, 131, 133, 136, 137, 146, 6 76,
80, 97, 124, 131, 146

, 3 81, 98, 142, and 1 125, respectively (Figure 2.7.). The 2 most common land uses,

crop cultivation and livestock rearing, were both present in 5 of studies 80, 97, 124, 131, 146.
There were 13/34 studies from the C. paraensis search that described land use (Figure 6).
The most common use of land was crop cultivation (9 studies) 92, 147, 152, 155, 156, 171, 175, 177, 179,
followed by livestock (7 studies) 147, 158, 164, 166, 169, 171, 175. In studies, crop cultivation and
livestock were noted 147, 171, 175.
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Figure 2.7. (Blue) There were 18/56 studies that including information about anthropogenic land use. The two most
common themes were agriculture and livestock, which overlapped in some locations. (Red) There were 13/34
studies with information about study site land use. There were 3 studies where livestock and cultivation overlapped.

2.3.4.4. Water source
In 19 of the 56 articles focusing on OROV surveillance, a nearby water source was noted
(Figure 7). In 14 locations there was at least one river present 36, 97, 98, 106, 113, 124, 126, 127, 131, 135-138,
146

. Other sources of water were noted but to a much lesser extent with 3 locations in the

Pantanal (the largest tropical wetland in the world) 76, 114, 117, 2 locations in a coastal area 119, 123,
and 2 location near a dam 36, 132.
We found that water sources were mentioned in 21 of the 34 articles regarding C.
paraenesis surveillance (Figure 2.8.). The presence of at least 1 river was described in 11/21
articles 147-149, 152, 160, 161, 169, 173, 176, 177, 179. Streams were the second most frequently mentioned in
5 articles92, 156, 157, 175, 177. There were 4 studies that noted marshes/swamps 156, 166, 174, 179, whereas
coastal locations 158, 161, lakes 150, 153, 156, floodplains 150, 162, and springs 153, 156 were all water
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sources mentioned twice each. There was 1 location where surveillance took place at the site of a
dam 149 and 1 study that took place in the Pantanal 150.
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Figure 2.8. (Blue) 19/56 studies including information regarding water sources in their study areas. Overlap in water
sources in 1 location. (Red) There were 21/34 studies with information about water sources. There were overlap in
marshland, lakes, and springs.

2.3.4.5. Land Cover
There were 21 (38.9%) articles that made observations regarding land cover from the 56
studies that focused on OROV surveillance (Figure 2.9.). Locations that have primary or
undisturbed forest were most common, mentioned in 16 studies 39, 43, 77, 79, 81, 95-98, 127, 133-136, 139,
142

. Secondary forests, or forest locations that had been previously used for anthropogenic

purposes were found in 2 studies77, 137. A cerrado land cover, which consists of bushy, small bent
and twisted trunk trees, was described in 4 locations 113, 114, 117, 134, while 2 locations described
mountainous terrain 79, 125.
Of the 34 studies from the C. paraensis search, 26 (76.5%) that made note of the land
cover (Figure 8). Primary and secondary forest locations were noted in 16 92, 148, 150, 152, 156, 157, 162,
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165, 166, 169, 171, 174-177, 179

and 11 studies 147, 149, 151, 153, 155, 159, 166, 168, 169, 171, 173, respectively. There

were 3 surveillance studies that took place in locations described as cerrado 150, 151, 179, while both
mangrove 158, 179 and restinga land cover 165, 167 types were mentioned. Restinga refers to coastal
forests with the soil mostly consisting of sand and salt. There were several studies that had
overlapping types of land cover which included cerrado, primary forest, and secondary forest
locations 150, 151, 165, 166, 169, 171, 179.
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Figure 2.9. (Blue) There were 21 studies that included information about the land cover of the study area. There
were overlap of land cover types in 3 locations. (Red) There were 26/34 studies with information about the land
cover types associated with the study sites. There were overlaps in primary and secondary forest, primary forest and
cerrado, cerrado and secondary forest, primary forest and restinga, and one study included mangrove, cerrado and
primary forest sites.

2.3.5. Statistical analysis
2.3.5.1. Odds of Detecting Acute and Past Infections
The full model run with all 12 variables did not converge for either the dataset built on
pcr prevalence (acute infections) or antibody prevalence (past infections). The use of high
computing power may allow for convergence in future but was not available at the time of
writing. Due to the small dataset and the large number of variables, we next employed a data
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reduction method and ran the model with uni-, bi-, and tri-variate combinations of the
variables related to anthropological land-use, the presence of water, and/or forests. In none of
the models were any variables significant for either the acute or past infections.
2.3.5.2. Odds of Vector Presence
Similarly, the full model of 17 eco-environmental variables for determining differences in
odds of detection of the vector species did not converge. None of the uni-, bi-, or tri-variate
models run using the data reduction methods returned significant results. This suggests that,
in South America, there is still not enough data available to determine whether the detection
of Culicoides pariensis is likely to be associated with specific eco-environmental variables.
2.4. Discussion
Our primary objective was to assemble the existing data regarding the environmental and
ecological factors associated with known detection of OROV in South America, and to likewise
identify factors associated with the presence of the primary enzootic vector. Our review of the
published data demonstrates that there are similarities among the factors observed in OROV and
vector detection. First, the most prominent anthropogenic land use observed was crop cultivation
and livestock for both OROV and vector presence. Secondly, rivers were the most common
source of water in locations where OROV and arthropod vectors were documented. Lastly, both
OROV and vectors were more frequently found in primary forest locations.
Because OROV is an arbovirus, the presence of a vector is paramount to the likelihood of
virus detection 90, 91. Arbovirus transmission potential is measured largely by the vectorial
compacity equation, which investigates key variables including such factors as vector density
relative to humans, and extrinsic and intrinsic factors that govern the virus-vector dynamics 180.
Often, the processes of transmission within the vector - vector competence and the EIP – are
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affected by environmental factors, most notably temperature, which can vary in response to
anthropogenic land use, land cover, and proximity to water 18, 20, 181, 182. Therefore, these
environmental and ecological characteristics are crucial factors that should be considered in
OROV transmission and when planning efforts aimed at detecting this potentially emergent
arbovirus.
For example, because a good portion of the C. paraenesis lifecycle includes semi-aquatic
stages, these arthropods are often found in moist, decaying vegetation such as that from recently
harvested farms 182. C. paraensis often lay eggs in moist areas, where developmental stages
progress through the lifecycle by feeding on decomposing organic matter, algae, and small
vertebrate prey 182. The necessity of water to the lifecycle of C. paraensis (as well as the
secondary mosquito vectors) increases the likelihood of finding these arthropods in close
proximity to water sources 182. In addition, water is an attractant to susceptible vertebrate hosts in
both uninhabited and inhabited locations, which leads to host-vector interactions necessary for
arboviral transmission in the context of potential reservoir hosts, such as avians, non-human
primates, and rodents 18. While C. paraensis is known to feed on humans, their opportunistic
feeding patterns lead them to feed on other vertebrate hosts in lieu of human presence 182. In
addition, forested environments suitable for reservoir hosts enables arthropod vectors to both
acquire and transmit OROV 18, 182.
The increasing demand for agricultural and industrial products has resulted in worldwide
globalization183. The proceeding economic expansion into S. America centers around crop
production, especially soy, while some areas also take part in the livestock trade 183, 184. In
addition, mining for bauxite, nickel, and gold have had a positive impact on economic
development in this region 185. However, these economic gains have had unintended
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consequences whereby previously uninhabited forest are now in closer proximity to human
populations and/or human enterprises. This, in turn, increases the chances of zoonotic spillover
events by increasing contact between vector and reservoir vertebrate host populations 88.
There are numerous locations across regions of South America where investigations into
the presence of OROV have successfully identified circulation of the virus; however, it is
noteworthy that there are geographic gaps in OROV surveillance efforts. These data demonstrate
that there was no evidence of surveillance for OROV is noted in Colombia, Venezuela, and
Guyana, even though all three of these countries border Brazil. Colombia, particularly, borders
three countries where OROV has been identified (Figure 3A). Further, of the included records
the Google Scholar “Culicoides paraensis” and “South America” search, entomological
surveillance efforts for the primary vector of OROV in South America are predominantly in
Brazil, especially on the easternmost portion of the country (Figure 4).
There are obvious gaps in the literature concerning OROV, a neglected tropical, zoonotic
disease of emergent public health importance. The most surveillance has been conducted in
Brazil (Figure 2). While one C. paraensis surveillance study in Colombia verified the presence
of the vector, entomological surveillance specific to C. paraensis was also found to be primarily
concentrated in Brazil, with sporadic surveillance locations in Peru and Argentina 157, 170, 177.
Additionally, our review provided a preliminary characterization of ecological and
environmental factors that may be associated with increased chances of OROV detection and
perhaps circulation. However, continued research is needed to fully elucidate OROV
transmission dynamics, arthropod vector competence, and OROV distribution in order to prepare
for future emergence or expansion of this public health threat.
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2.5. Conclusion
There were notable common ecological aspects associated with both the locations
involved in OROV detection and the presence of the vector in the 94 studies included in this
systematic review. Ecological characteristics included in both OROV and arthropod vector
surveillance studies had crop cultivation as the most common anthropogenic use of land, rivers
as the most common water source, and primary forest as the most prominent type of land cover.
The observations found within this systematic review illustrate the importance of including
research into the ecological factors associated with the distribution of under-characterized
arboviruses. This review reveals the need for continued surveillance for OROV and its arthropod
vector, and the description of factors associated with detection may help to prioritize OROV
surveillance initiatives.
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CHAPTER 3. OROV AS A POSSIBLE ETIOLOGY FOR FEVERS OF
UNKNOWN ORIGIN IN A CLINICAL COHORT FROM COLOMBIA
3.1. Introduction
Arboviruses are a cause of public health concern due to the variety of clinical symptoms
ranging from mild febrile illness to death 21, 22. Zika virus (ZIKV), dengue virus (DENV),
Chikungunya (CHIKV) virus, and yellow fever virus (YFV) are well-known arboviruses that can
result in a number of human illnesses 21. These viruses can have similar symptomology
spectrum, which includes a mild febrile illness 28, 43, 48, 71. A lack of resources available to
diagnose and treat patients can also lead to misdiagnosis or an ultimate lack of definitive
diagnosis. In these cases, patients are released with a non-descript diagnosis of fever of unknown
origin. In fact, studies published from 1961 to 2007 show an increasing trend from 9.0% to
51.0%, respectively, in a result of no specific diagnosis of febrile patients 186.
With the emergence of new viruses, and/or increase in cases of existing viral febrile illness,
there is a need to expand screening of febrile patients for viruses that may not be immediately
considered in differential diagnosis. Determining the presence or absence of arbovirus circulation
in human populations, especially in febrile populations, would lead to a more comprehensive
view of disease burden resulting from a specific virus. Further, increasing the knowledge of viral
presence and circulation can inform efforts of surveillance and prevention programs42 .
OROV has been found in human patients in numerous countries that share border with
Colombia: Ecuador, Peru, Brazil 34, 35. Although there have not been any documented cases of
OROV in Colombia, the presence of C. paraensis, the primary vector of OROV has been
documented in Colombia 92. We undertook to test a clinical cohort of febrile patients from
Colombia to determine if the fevers were due to acute infection with OROV.
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3.2. Materials and Methods
3.2.1. Patient samples
Serum samples were obtained between 2013 and 2015 from patients in Colombia at Ese Hospital
Universitario Erasmo Meoz, Ese Hospital de Los Patios, Ese Hospital Emiro Quintero Cañizares,
from the regions of Cucuta, Los Patios, and Ocaña, respectively (LSU IRB protocol #3415).
Patients were classified as patients with suspected DENV, healthy controls, and non-DENV
febrile control patients.
3.2.2. Cell culture and virus growth
OROV DEI 209 was isolated from human serum in a patient from Iquitos in 1995 and provided
by the World Reference Center for Emerging Viruses and Arboviruses (WRCEVA), Galveston,
TX. The virus was received as lyophilized stock and reconstituted in 1 mL of BA-1 diluent (10%
Medium 199 (10X), Earle’s Salts, 1% Pen/Strep/Fungizone, 10% Bovine Serum Albumin, 0.6%
Tris-HCL, 0.47% Sodium Bicarbonate 7.5). Virus was then passaged once on Vero cells (ATCC
CRL-2587). Vero cells were grown at 37°C and 5% CO2 in optimal medium (88% Medium 199,
Earle’s Salts, 10% Fetal Bovine Serum, and 2% Antibiotic-Antimycotic). Confluent Vero cells in
a T25 flask were inoculated with 50uL OROV and supernatant was collected at 2 dpi (days post
inoculation). Frozen viral stocks of DENV serotype 2, strain 1232 that was passaged 10 times on
Vero cells was used for all DENV experiments 3.
3.2.3. OROV characterization
3.2.3.1. Growth Curve
To determine the in vitro growth kinetics of OROV, in our laboratory, aliquots of 200 uL was
collected on days 1, 2, 3, 5, and 7 post-inoculation on to confluent Vero cells. RNA was
extracted using the QIAmp Viral RNA Mini Kit per manufacturer’s instructions. 100 uL of
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sample was added into 400 uL of AVL buffer and gently mixed followed by a 10-minute
incubation for virus inactivation. 400 uL of ethanol was added to the mixture and briefly
vortexed. Mixture was then added to the Qiagen Mini spin column and centrifuged. Filtrate was
discarded and 500 uL of AW1 solution added to the Qiagen Mini spin column and centrifuged.
Filtrate was discarded and 500 uL of AW2 solution was added to the Qiagen Mini spin column
and centrifuged. Filtrate was discarded and 60 uL of Elution AVE was added to the Qiagen Mini
spin column and was incubated then centrifuged. The resulting filtrate is extracted viral RNA
from original sample. Quantitative Reverse Transcription-Polymerase Chain Reaction (qRTPCR) was performed on extracted viral RNA as described below. The growth curve for OROV
revealed maximum growth on 3 dpi.
3.2.3.2. Plaque Assay and Viral Titer Determination
Vero cells were grown as described above in T75 flasks until confluent. Growth media was
removed, and cells were trypsinized then seeded in 6-well plates. Cells were monitored for 12-24
hours until 100% confluent and adhered to well bottoms. A 10-fold virus dilution series was
prepared from -1 to -7. Growth media was removed, and cells were inoculated with respective
dilutions then plates were rocked for 30 minutes. 2 mLs of overlay mixture that consisted of a
1:1 ratio of media (0.2% 10X Medium 199, Earle’s Salts, 0.032% Sodium Bicarbonate, 0.05%
1M Hepes, 0.02% Pen/Strep/Fungizone, 0.2% Fetal Bovine Serum, 0.49% water) and agar (0.25
g SeaPlaque agar power dissolved in 25 mLwater) was applied to cell layers. Plates were
incubated at 37°C and 5% CO2 until plaque were noticed under microscopic examination. On
day 4 post inoculation 3 mLs of 10% formaldehyde solution was applied to each well for 1 hour.
Formaldehyde waste and overlay were moved and 1 mL of 0.35% crystal violet solution was
applied to each well. Plates were incubated for 15 minutes, crystal violet was discarded, plates
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were rinsed with water and allowed to dry overnight. Plaques were counted and the titer of
OROV was calculated to be 8.73 x 107 PFU/mL. The titer of DENV serotype 2 strain 1232 was
calculated to 4 x 107 PFU/mL.
3.2.4. RNA Extraction and qRT-PCR assays
RNA was extracted using the KingFisher (ThermoFisher) robot and the Ambion MagMag viral
isolation kit (ThermoFisher), per manufacturer’s instructions. Extracted RNA samples were then
tested for the presence of OROV RNA using the OROV S segment previously published
101

(Table 3.1.). In addition, samples were screened for the presence of DENV RNA using a pan-

DENV primer and probe set previously published187 . All primers and probes used are listed in
Table 3.1. Prior to experiments, primer and probe pairs were tested on appropriate viral stocks
for validation. OROV qRT-PCR screening was performed by preparing of mixture of 10µL 2X
RT buffer, 1µL Forward primer (10 µM), 1µL Reverse primer (10 µM), 0.4 µL Probe (20 µM),
0.4 µL SIII Taq, 1.4 µL ddH2O, 0.8 µL MgSO4 and 5µL sample RNA was used on 96-well PCR
plates. After being loaded, plates were centrifuged for 2 mins at 2000 rpm prior to nucleic acid
amplification on a Roche LightCycler 96. The OROV S segment screening involved the
following thermocycling parameters: reverse transcription at 50°C for 300 seconds, then 95°C
for 20 seconds, and 2-step amplification at 45 cycles of 95°C for 3 seconds and 60°C for 30
seconds 101. DENV qRT-PCR was performed by preparing a mixture of 10µL 2X RT buffer, 1µL
Forward primer (10 µM), 1µL Reverse primer A (10 µM), Reverse primer B (10 µM), 0.4 µL
Probe (20 µM), 0.4 µL SIII Taq, 0.4 µL ddH2O, 0.8 µL MgSO4 and 5µL sample RNA was used
on 96-well PCR plates. After being loaded, plates were centrifuged for 2 mins at 2000 rpm prior
to nucleic acid amplification on a Roche LightCycler 96. To detect DENV the following
thermocycling parameters were applied: reverse transcription at 45°C for 30 seconds, then 95°C
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for 5 minutes, 2-step amplification at 45 cycles at 95°C for 45 seconds and 57°C for 35 seconds
187

. Each qRT-PCR run included a positive hand extracted RNA sample from the target virus and

two negative controls (molecular grade water, PCR mixture without sample RNA). Samples with
a Cq value of ≤ 35 were considered positive.
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Table 3.1. Primers and Probes used for qRT-PCR
Virus and target segment

Primer and

Sequence

Tm °C

Forward primer

5’ TCCGGAGGCAGCATATGTG 3’

57.3°C

Reverse primer

5’ ACAACACCAGCATTGAGCACTT 3’

57.6°C

Probe

5’ (FAM) CATTTGAAGCTAGATACGG 3’

47.8°C

Pan-DENV 3’ noncoding

Forward primer

5’ GGATAGACCAGAGATCCTGCTGT 3’

57.7°C

region

Reverse primer

5’ CATTCCATTTTCTGGCGTTC 3’

52.3°C

5’ CAATCCATCTTGCGGCGCTC 3’

59.4°C

5’ CAGCATCATTCCAGGCACAG 3’

57.9·C

Probe
OROV Small segment

A (1:1)
Reverse primer
B (1:1)
Probe

*Reverse primer A and B were mixed at a 1:1 ratio
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3.3. Results
Human serum samples available from Cucuta (n = 176), Los Patios (n = 262), and Ocaña
(n=261) that were classified as “suspect DENV” patients or “febrile, not DENV suspect” patients
(Table 3.2.). Each of these samples were screened for DENV and OROV. Of the 699 samples,
608 (87%) of them were collected as “DENV suspect” patients, whereas only 91 (13%) were
classified as “febrile, not DENV suspect” patients. Sample demographics are described in table
3.2.
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Table 3.2. Human Serum Sample Demographics
Location

Cucuta DENV

Los Patios DENV

Los Patios Febrile, non-

Ocana DENV

Ocana Febrile, non-

Suspect

Suspect (n=186)

DENV suspect (n=76)

Suspect (n=246)

DENV suspect (n=15)

(n=176)

Total (n=699)

*1 unknown gender

Male

89

102

41

107

11

350

Female

87

84

34

139

4

348

Age 0-15

153

99

39

105

8

404

Age 16-30 16

45

13

78

4

156

Age 31-45 2

9

12

34

1

58

Age 46-60 4

17

2

21

2

46

Age 61+

1

16

10

8

0

35

2014

0

129

11

111

0

251

176

57

65

135

15

448

Collection
2015
Collection
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We found that only 19 out of the total 699 samples were DENV positive via qRT-PCR,
while there were no positive samples for OROV. Of these positive DENV samples, 2 of them
were categorized as “febrile, not DENV suspect” patients. In Cucuta, of the 176 samples
screened for DENV, there was 1 positive sample (0.006%). This patient was classified as a
“DENV suspect” patient. There was 262 samples tested from Los Patios and 12 of these were
positive for DENV (0.046%). A total of 261 samples were tested for DENV from Ocaña,
revealing 6 positive patients (0.02%). Each of these 6 patients were classified as “DENV
suspect” patients. Of the 12 positive samples from Los Patios, 10 of the samples were collected
from “DENV suspect” patients, whereas 2 samples were in the collected from the group of
“febrile, not DENV suspect” patients.
All samples were negative for OROV S segment via RT-qPCR. The S segment was
targeted to expand upon our surveillance efforts, encompassing OROV reassortants Iquitos virus
(IQTV), Madre de Dios virus (MDDV), and Perdões virus (PERDV). Each of these OROV
reassortants contain the same S segment 87. These results reveal that 680/699 (97%) of the
patients experienced febrile illness from etiologic agents other than OROV and DENV.
3.4. Discussion and Conclusions
The clinical manifestation during the early stages of OROV infection mimic those of
other arboviruses endemic in Latin America 43. This can lead to misdiagnosis and
underreporting, therefore skewing any epidemiological data available 35. Because of the nonspecific generalized febrile illness associated with the majority of OROV infections, testing for
OROV should not be completely ruled out.
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Our results involved screening 699 human patient serum samples for the presence of
OROV and molecular confirmation of acute DENV. This illustrates the importance of additional
screening for various etiologic agents of febrile illness in Colombia, however we demonstrated
that the inclusion of OROV did not reveal the etiology of these non-specific pathologies. Broader
surveillance for OROV can be done by the addition of other detection methods, expanding
geographical ranges, and OROV reservoir and vector surveillance.
There are a variety of pathogens that cause febrile illness in the Colombian human
population and may be undiagnosed etiologies in cohorts such as this. Viruses including YFV,
ZIKV, DENV, CHIKV, Mayaro virus (MAYV), and Venezuelan equine encephalitis virus
(VEEV) are all arboviruses transmitted by arthropod vectors and can result in febrile illness 28,
188-190

. In addition, parasites that cause malaria and chagas disease, which are transmitted

mosquitoes and triatomine bugs, respectively, cause febrile illness and have been found to
circulate in Colombia 191-193. Rickettsia, a tick-borne disease resulting in febrile illness during
human infections has also been found in Colombian populations 194. Additionally, there is still
the potential for febrile illness to stem from currently unknown or neglected emerging pathogens.
By increasing surveillance for arboviruses in human, vector, and animal populations, we
can close some of the knowledge gaps regarding neglected tropical disease epidemiology
including transmission, distribution, and characteristic disease symptoms. This could also inform
future preventative and preparedness measures for future outbreaks of emerging viruses.

41

CONCLUSIONS
Arboviruses are a continuing threat to human and animal health as vectors,
viruses, and hosts are increasingly interacting through expanding urbanization and
globalization12. Urbanization as a result of population growth has increased the interface of
vector and human interaction, especially with those vectors that are anthropophilic 12, 13.
Arboviral vectors such as Aedes mosquito spp. have expanded their geographic range and are
found worldwide 195. Expanding globalization and world travel aids in the disease spread
potential by facilitating pathogen spread between countries 196. Surveillance efforts are needed to
monitor emerging pathogens more than ever because of these factors contributing to the potential
for disease spread worldwide 13, 196. The advances in research and medical fields only enhances
the speed at which promising solutions can be reached for prevention and treatment upon a threat
or outbreak of an emerging disease 197, 198.
Arbovirus spread has been found to occur for decades or more as Eastern hemisphere
viruses are introduced and expand into the Western hemisphere. Yellow fever virus, CHIKV, and
ZIKV are examples of arboviruses that originated in the Eastern hemisphere and were introduced
into the Western hemisphere, resulting in large outbreaks with high levels of morbidity and
mortality in naïve populations 199. The occurrence of these outbreaks prompted increased
research efforts to understand transmission, pathogenesis, treatment, and prevention to combat
future outbreaks199. Increasing knowledge of a pathogen is valuable for the next steps to prevent
further viral spread and economic damage56, 200, 201 . This supports the need for surveillance
efforts to gain knowledge about potential disease-causing pathogens and could aid in prevention
of large outbreaks before they occur or be able to initiate a response in a timely manner to an
outbreak 42, 57, 202.
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Ecological characteristics such as temperature and precipitation are known to have effects
on arbovirus transmission 62, 63. These factors have been used to train data sets to make
projections for future arbovirus outbreaks 58, 64. Knowledge regarding transmission dynamics of
OROV is still being researched as more outbreaks are occurring, specifically in Latin America100,
203

. While OROV has been found in these areas, it has been included in diagnostic algorithms

after more common arboviruses have been ruled out via diagnostic methods such as PCR39, 104 .
The addition of OROV screening to passive surveillance systems could close some gaps
in knowledge regarding the number of OROV cases and virus distribution 34, 37. In addition to
patient sample screening, implementing arthropod surveillance for OROV could reveal the
presence or absence of OROV in urban and sylvatic arthropod populations. Vector surveillance
could also inform preventative measures for human exposure to potentially infectious arthropods.
The objective of the systematic review in Chapter 2 was to use published literature to
identify economical and environmental characteristics to aid in guiding surveillance efforts. We
were hoping to use this data to inform locations that would have a higher likelihood of detecting
the presence of OROV. Ultimately, this data did not reveal any significant differences among
ecological and environmental characteristics between 3 Colombian locations: Cucuta, Los Patios,
and Ocaña.
In Chapter 3, the goal was to screen for the presence of OROV in a clinical cohort of
febrile patients from Colombia. Without any clear location to prioritize, we tested all available
human serum samples from each of the three locations to determine if differences existed in the
detection of OROV. Each of the samples was from a patient presenting with febrile illness. Each
of these samples was tested via RT-qPCR for OROV and DENV. DENV was tested due to its
endemicity in Colombia and the antibody-based test for DENV suspicion in the clinic. We found
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that none of the patients had an acute infection of OROV, while 19 out of 699 patients were
positive for DENV, despite 608 samples being classified as DENV-suspect from the clinical
data. This could be due to the nature of DENV diagnostics, which is antibody based (IgM and
IgG) and which therefore detect convalescent infections. Regardless, this suggests that other
etiologies are responsible for a majority of fevers of unknown origin, but that OROV is not likely
to contribute to that burden of disease in Colombia.
Gaining insight into pathogen transmission, distribution, and characteristic disease
symptoms can aid in preventative measures, preparedness, and response (e.g., targeted vector
control). Ultimately, augmented surveillance data can contribute to modeling efforts, which have
been used in decision making during ongoing outbreaks to distribute resources. Despite the
results herein, there is a continued need for surveillance of neglected tropical diseased and
emerging viruses to bridge gaps in knowledge and proactively understand the dynamics of
emergence and expansion of these pathogens.
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APPENDIX. SYSTEMATIC REVIEW ARTICLES
Articles meeting all inclusion criteria for literature search of OROV and C. paraensis. * indicates
articles included from C. paraensis database search
TITLE
Oropouche Virus: a New Human Disease Agent from Trinidad, West
Indies
Occurance of arboviruses belonging to the C-, Bunyamwera and Guama
groups, and of Oropouche, Junin, Tacaiuma and Kwatta viruse in man in
the province of Brokopondo, Surinam: a serological survey
An outbreak of Oropouche virus disease in the vicinity of santarem, para,
barzil
Oropouche Virus II. Epidemiological Observations During an Epidemic in
Santarem, Para, Brazilian 1975
Epidemic Oropouche virus disease in northern Brazil
Oropouche Virus Transmission in the Amazon River Basin of Peru
Venezuelan Equine Encephalitis and Oropouche Virus Infections among
Peruvian Army Troops in the Amazon Region of Peru
Epidemiology of endemic Oropouche virus transmission in upper
Amazonian Peru
Serologic survey for yellow fever virus and other arboviruses among
inhabitants of Rio Branco, Brazil, before and 3 months after receiving the
YF 17D vaccine
Exanthematous diseases and the 1st epidemic of dengue virus to occur in
Manaus, Amazonas State, Brazil, during 1998-1999
Reemergence of Oropouche fever, northern Brazil
Assessing yellow fever risk in the Ecuadorian Amazon
Oropouche fever epidemic in Northern Brazil: Epidemiology and
molecular characterization of isolates
Sporadic Oropouche infection, Acre, Brazil
Etiology of acute undifferentiated febrile illness in the Amazon basin of
Equador
Oropouche fever outbreak, Manaus, Brazil, 2007-2008
Detection of St. Louis Encephalitis virus in dengue-suspected cases during
a dengue 3 outbreak
Arboviral etiologies of acute febrile illnesses in Western S. America, 20002007
Iquitos virus: a novel reassortant Orthobunyavirus associated with human
illness in Peru
Short report: Identification of Oropouche orthbunyavirus in the
cerebrospinal fluid of 3 patients in the Amazonas, Brazil
Seroepidiological monitoring in sentinal animals and vectors as part of
arbovirus surveillance in the State of Mato Grosso do Sul, Brazil
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AUTHOR
C.R. Anderson, et
al.
HA van Tongeren
et al.
FP Pinheiro et al.
K.E. Dixon et al.
JW LeDuc et al.
DM Watts et al.
DM Watts et al.
KJ Baisley et al.
J Tavares-Neto et
al.
RM De Figueiredo
et al.
RS Azevedo et al.
RO Izurieta et al.
HB Vasconcelos et
al.
AC Bernardes et al.
SR Manock et al.
MP Mouraao et al.
ACB Terzian et al.
BM Forshey et al.
PV Aguilar et al.
M de Souza Bastos
et al.
PM Batista et al.

Detection of arboviruses of public health interest in free-living new world
primates captured in Mato Grosso do Sul, Brazil
Detection of herpesvirus, enterovirus, and arbovirus infection in patients
with suspected central nervous system (CNS) viral infection in the Western
Brazilian Amazon
Clinical and Virological Descriptive Study in the 2011 Outbreak of
Dengue in the Amazonas, Brazil
Detection of Oropouche virus segment S in patients and in Culex
quinquefasciatus in the state of Mato Grosso, Brazil
Detection of antibodies to Oropouche virus in non-human primates in
Goiania City, Goias
Serosurvey of selected abroviral pathogens in Free-ranging, 2-toed sloths
and 3-toed sloths in Costa Rica, 2005-07
Oropouche virus is detected in peripheral blood leukocytes from patients
Silent emergence of Mayaro and Oropouche viruses in humans and Central
Brazil
Neutralizing antibodies for orthobunyaviruses in Pantanal, Brazil
Emerging and reemerging arboviruses: A new threat in Eastern Peru
Human orthobunyavirus Infections, Tefe, Amazonas, Brazil
Isolation of Oropouche virus from febrile patient, Ecuador
Oropouche virus associated aseptic meningoencephalitis, SE Brazil
1st outbreak of Oropouche fever reported in a non-endemic western region
of the Peruvian Amazon: molecular diagnosis and clinical characteristics
Real time RT-PCR for the detection and quantification of Oropouche virus
Oropouche virus detection in febrile patients' saliva and urine samples in
Salvador, Bahia, Brazil
Oropouche virus cases identified in Ecuador using an optimized qRT-PCR
informed by metagenomic sequencing
Oropouche infection a neglected arbovirus in patients with acute febrile
illness from Peruvian coast
Oropouche virus detection in saliva and urine
1st register of an epidemic caused by Oropouche virus in the states of
Maranhao and Goias, Brazil
Outbreak of oropouche virus feveri n Serra Pelada, municpality of
Curionopolis, Para, 1994
Sera of Peruvians with fever of unknown origin include viral nucleic acids
from non-invertebrate hosts
Detection of Oropouche viral circulation in Madre de Dios region, Peru
(Dec 2015-Jan 2016)
Serological survey for arboviruses in Jururi, Para State, Brazil
Concurrent dengue and malaria in the Amazon region
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PM Batista et al.
MS Bastos et al.
V do Carmo Alves
Martins et al.
BF Cardoso et al.
MM Gibrail et al.
S Medlin et al.
LK de Souza Luna
et al.
VG da Costa et al.
A Pauvolid-Correa
et al.
C Alva-Urcia et al.
FG Naveca et al.
EL Wise et al.
S Vernal et al.
W Silva-Caso et al.
A Rojas et al.
LM dos Santos
Fonseca et al.
EL Wise et al.
J Martins-Luna et
al.
VA do Nascimento
et al.
PF Vasconcelos et
al.
AP Rosa et al.
TG Phan et al.
MP Garcia et al.
AC Cruz et al.
V dos Santos
Santana et al.

Oropouche virus Isolation, Southeast Brazil
Transmission of Oropouche virus from man to hampster by the midge
Culicoides paraensis
Lack of evidence of sylvatic transmission of dengue viruses in the Amazon
Rainforest near Iquitos, Peru
Diagnosis of Oropouche virus infection by RT-Nested-PCR
Arboviruses in blood-donors: a study in the amazon region and in a small
city with a dengue outbreak
The acre project: the epidemiology of malaria and arthropod-borne
infections in a rural Amazonian population
Seroepidemiology of arboviruses in communities living under the
influence of the lake of a hydroelectric dam in Brazil
Surveillance of arboviruses in primates and sloths in the Atlantic forest,
Bahia, Brazil
Arbovirus investigation in patients from Mato Grosso during Zika and
chickungunya virus introduction in Brazil, 2015-16
An epidemic of Oropouche virus in Belém. (Preliminary note).
Laboratory transmission of Oropouche virus by Culex Quinquefasciatus
Say.
Oropouche Virus IV. Laboratory Transmission by Culicoides paraensis
Laboratory studies of a Brazilian strain of Aedes albopictus as a potential
vector of Mayaro and Oropouche viruses
Detection of abs against Icoaraci, Ilheus, and St. Louis Encephalitus
arboviruses during yellow fever monitoring surveillance in Non-human
primates in S. Brazil
Culicoides paraenesis infestations in the cities of the Itapocu river valley,
S. Brazil*
Culicoides species and potential hosts in ecotourism area of Lencois
Maranhenses National park, Brazil*
New report on the bionomics of Coquillettidia venezuelensis in temporary
breeding sites *
Culicidae selection of humans, chickens and rabbits in 2 different
environments in the province of Chaco, Argentina*
Preliminary investigation of Culicidae species in south pantanal, Brazil and
their potential importance in arbovirus transmission*
Species Diversity, Seasonal, and Spatial Distribution of Mosquitoes
(Diptera: Culicidae) Captured in Aotus Monkey-Baited Traps in a Forested
Site Near Iquitos, Peru*
Seasonal distribution, biology, and human attraction patterns of culicine
mosquioes in a forest near Puerto almendras, Iquitoes, Peru*
Inventory of mosquitoes in conservation units in Brazilian tropical dry
forests*
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Marcio Roberto
Teixeira Nunes et
al.
FP Pinheiro et al.
MJ Turell et al.
ML Moreli et al.
Lavezzo et al.
Silva-Nunes et al.
Brito et al.
Catenacci et al.
Souza Costa et al.
Pinheiro et al.
AL Hoch et al.
F.P. Pinheiro et al.
GC Smith et al.
MAB Almeida et
al.
Felippe-Bauer et al.
Costa et al.
J Alencar et al.
Stein et al.
Pauvolid-Correa et
al.
Andrews et al.
Jones et al.
CF Santos et al.

Mosquitoes (Diptera: Culicidae) From the Northwestern Brazilian
Amazon: Padauari River*
Composition and diversity of mosquitoes in urban parks in the south region
of the city of Sao Paulo, Brazil*
Ecological aspects of the potential arbovirus vectors in an urban landscape
of S amazon, brazil*
Diversity patterns of hematophagous insects in Atlantic forest fragments
and human-modifed areas of southern Bahia, Brazil*
Mosquito fauna in parks in greater Sao Paulo, Brazil*
Spatial and temporal distribution of Culicoides insignis and C. paraenesis
in the subtropical mountain forest of Tucuman, northwest Argentina*
Changes in Relative Species Compositions of Biting Midges and an
Outbreak of Oropouche virus in Iquitos, Peru*
Preliminary survey on the sanitary nuisance caused by culicoides in the
department of Boyaca, Colombia*
A study of culicoides in Rondonia, in the Brazilian Amazon: species
comparison, relative abundance and potential vectors*
Culicoides from Ceara state, northwest Brazil: Diversity, new records and
bionomic approaches*
New records and epidemiological potential of certain species of mosquito
in the State of Rio Grande do Sul, Brazil*
Diversity of biting midges of the genus Culicoides Latreille in the area of
the Yacyreta Dam Lake between Argentina and Paraguay*
Biting Rates and Developmental Substrates for Biting Midges in Iquitos,
Peru*
Oropouche Virus III. Entomological observations from three epidemics in
Para, Brazil, 1975*
Dermatozoonosis by Culicoides’ Bite in Salvador, State of Bahia, Brazil*
Annotated list of the Ceratopogonidae (Diptera) of Suriname*
Diversity of Culicoides (diptera: Ceratopogonidae) in the National forest of
Caxiuana, Melgaco, Para State, Brazil*
New records of Culicoides Latreille (Diptera: Ceratopogonidae) from
Peruvian Amazonian region*
List of Culicoides biting midges (Diptera: Ceratopogonidae) from the state
of Amazonas, Brazil, including new records*
Simuliid Blackflies (Diptera: Simuliidae) and Ceratopogonid Midges
(Diptera: Ceratopogonidae) as Vectors of Mansonella ozzardi (Nematoda:
Onchocercidae) in Northern Argentina*
New records of biting midges of the genus Culicoides Latreille from
Mexico (Diptera: Ceratopogonidae)*
Seasonal abundance of livestock-associated Culicoides species in
northeastern Brazil*
Infestation of Brazilian Peridomiciliary Areas by Culicoides (Diptera:
Ceratopogonidae) in Humid and Semihumid Climates*
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control of culicoides in northeastern Brazil*
Isolation of viruses from mosquitoes collected In the Amazon basin region
of Peru*
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